MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.
CONCLUSIONS: Despite variation in size and location within the pelvis, ≥ 50 % of tumour volumes were considered targetable in 55 % patients while avoiding adjacent critical structures. A prospective treatment study will assess safety and symptom relief in a second patient cohort.
ADVANCES IN KNOWLEDGE: Target size, location and access make MRgHIFU a viable treatment modality for treating symptomatic recurrent gynaecological tumours within the pelvis.
PMID: 31084495 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Giles SL, Imseeh G, Rivens I, Ter Haar GR, Taylor A, deSouza NM Tags: Br J Radiol Source Type: research
More News: High Intensity Focused Ultrasound Therapy | OBGYN | PET Scan | Radiology | Study | UK Health | Ultrasound